Skip to content
MyFreud

Mindfulness tested as an add-on to anxiety medication

A trial gave 106 medicated adults with GAD either eight weeks of mindfulness or psychoeducation. The mindfulness group improved more on every measure taken.

3 min read

Pop-art illustration of two people talking in a counselling session.

Key takeaways

  • Everyone in the trial stayed on their medication. This tests mindfulness as an addition, not as an alternative.
  • The comparison group got structured psychoeducation rather than nothing, which is a much fairer test than the waiting lists these trials usually use.
  • Sleep, negative thinking patterns and psychosocial functioning all improved alongside the anxiety score, which is the part that matters for daily life.
  • The primary outcome was clinician-rated rather than self-reported, though clinicians appear not to have been blinded.

Medication for generalised anxiety disorder often takes the edge off without finishing the job. People describe being less overwhelmed but still braced, sleeping badly, still caught in the same loops. The clinical question is what to add, and a trial published in Frontiers in psychiatry in 2026 tested one answer under conditions fairer than these studies usually manage. [pubmed-anxiety-jun25-2026-source]

What the researchers did

One hundred and six adults with a diagnosis of generalised anxiety disorder, all already on stable medication, were randomly split in two. Half received an eight-week group mindfulness course adapted from mindfulness-based cognitive therapy, on top of their medication. Half received structured psychoeducation, also on top of their medication.

That control condition is the reason this trial is worth attention. The usual comparison in mindfulness research is a waiting list, which hands the intervention group eight weeks of structure, group contact and the expectation of getting better while the comparison group gets nothing at all. Any of those will move a score without the meditation contributing anything. Giving both groups a real programme removes most of that objection.

The main outcome was clinician-rated anxiety severity. Secondary measures covered self-rated anxiety, mindfulness skills, sleep quality, negative thinking patterns and overall functioning.

What they found

The mindfulness group improved more on clinician-rated anxiety, and the difference grew over the eight weeks rather than appearing all at once.

Every secondary measure moved the same way. Self-rated anxiety, mindfulness skills, sleep quality, negative cognitive bias and psychosocial functioning all favoured the mindfulness group.

That breadth is worth noticing. Sleep and functioning are the things people actually describe when asked whether they are better, and they often lag behind the symptom score.

How much weight to give it

One hundred and six people is a reasonable size for this kind of trial without being large. The bigger caveat is blinding: the report does not indicate that the clinicians doing the ratings were blind to which group each participant was in, and an unblinded rater on the primary outcome is a real weakness however good the control condition is.

There is also the question of what the psychoeducation group expected. Being told you are receiving the educational arm rather than the mindfulness arm is not neutral, even when both are structured.

What this means in practice

The practical shape of this finding is narrow and useful. If you are on medication for anxiety and it has helped but not enough, a structured mindfulness course is a reasonable thing to ask about, and the evidence is for the eight-week guided group format rather than for meditating on your own with an app.

It is an addition. Nothing in this trial speaks to stopping medication, and some anxiety medications are unsafe to stop abruptly.

What the practice actually involves

A structured course is eight weeks of this, guided, with a group. This is only a taste of the raw material: sit, and pay attention to the breath without trying to change it.

3:00

Your attention will wander. Noticing that it has wandered and coming back is the practice, not a failure of it.

The source

These findings are drawn from “Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial” (Zhang C, Zhang J, Sun L, 2026), published in Frontiers in psychiatry. Read the full study on PubMed.

Frequently asked questions

Can mindfulness replace anxiety medication?

Nothing here supports that, and the trial was not built to test it. Every participant stayed on stable medication throughout, so what was measured is what mindfulness adds on top. Stopping a prescribed medication is a decision to make with the doctor who prescribed it, and abruptly stopping some anxiety medications is genuinely unsafe.

Why does the comparison group matter here?

Because most mindfulness trials compare against a waiting list, which means the mindfulness group gets eight weeks of structure, attention and the expectation of improvement while the control group gets none of those. Any of that alone will move a score. Here the control group received structured psychoeducation, so both groups had somewhere to be and something to do. That makes the difference between them more attributable to the mindfulness itself.

What was the intervention, exactly?

An eight-week group programme adapted from mindfulness-based cognitive therapy, which combines meditation practice with cognitive-therapy elements. It is a structured course with weekly sessions and home practice, not an app and not unguided meditation. That distinction matters if you are trying to reproduce it: the evidence base sits on the structured group format.

Is negative thinking really something mindfulness changes?

The trial measured it and found improvement, and the proposed mechanism is plausible: the practice trains you to notice a thought arriving rather than being carried along by it, which is the point at which a spiral can be interrupted. Whether that is really what changed, or whether people simply rated themselves as less negative after eight positive weeks, this design cannot separate.

References

  1. 1.Zhang C, Zhang J, Sun L ( 2026). Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial. Frontiers in psychiatry. pubmed.ncbi.nlm.nih.gov . doi:10.3389/fpsyt.2026.1810049